Pickton

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pickton

Quick Facts about Pickton

Property Description
Active ingredient Baclofen
Form Tablet (oral formulation), Sterile solution for injection
Pharmacological class Centrally acting skeletal muscle relaxant / Antispastic agent
General purpose Management of pathological muscle stiffness (spasticity)
Origin Synthetic compound (GABA derivative)
Differentiating Feature Highly effective for flexor spasms associated with spinal cord damage

What Type of Drug is Pickton (Baclofen)?

Pickton is a prescription-only medication classified as a centrally acting skeletal muscle relaxant used primarily for managing severe muscle stiffness and spasms. Its sole active ingredient is Baclofen, which is an antispastic agent belonging to the pharmacological class of centrally acting skeletal muscle relaxants. Baclofen is a synthetic compound chemically derived from Gamma-aminobutyric acid (GABA). The term "centrally acting" signifies that it functions directly within the central nervous system (CNS)—specifically the spinal cord—to regulate the nerve signals that control muscle tone, distinguishing its site of action from agents that act only on the muscle itself.


Composition and Available Forms of Pickton

The core component of Pickton is the substance Baclofen, which is formulated alongside pharmaceutical excipients for delivery. Baclofen plays a foundational role in therapeutic protocols for neurological disorders. It is available in two main dosage forms: the commonly used tablet for oral formulation and a sterile solution for injection utilized in specialized procedures. The availability of both the standard oral form and the highly concentrated solution provides physicians with flexibility in treating patients whose severe spasticity is unresponsive to oral therapy.


Pickton's General Therapeutic Purpose and Action

The general therapeutic purpose of this medication is to provide relief from pathological muscle tension, known as spasticity, which is often associated with chronic neurological disorders, such as multiple sclerosis or spinal cord lesions. Baclofen is used as an agent for managing spasticity, reducing the frequency and severity of painful muscle contractions. This effect is achieved by the drug regulating inhibitory nerve pathways, which helps reduce involuntary muscle stiffness and spasms (hypertonia), ultimately promoting improved mobility and comfort.

Regulatory References

  1. Baclofen - StatPearls - NIH
  2. NIH Baclofen Efficacy StatPearls article

What side effects are possible with Pickton?

Possible Side Effects and Safety Information

The official safety characteristics of Pickton (Baclofen) are classified based on the documented frequency and the physiological systems affected, derived from government regulatory documents.

Adverse effects are most often observed at the start of treatment or following rapid dose increases, reflecting the medication's primary action on the central nervous system (CNS).


Frequency-Defined Adverse Reactions

The official labeling organizes side effects into frequency categories:

  • Very Common (ge 10%): Primarily Drowsiness (somnolence), Muscle Weakness (hypotonia), and Nausea.
  • Common (1-10%): Includes Dizziness, Headache, Fatigue, Confusion, Hypotension (low blood pressure), Insomnia, and Respiratory Depression.
  • Uncommon/Rare (<1%): Examples include Suicidal Ideation, Abnormal Hepatic Function, and Erectile Dysfunction.

Side effects are categorized by the affected System-Organ Class (SOC), including Nervous System Disorders, Gastrointestinal Disorders, and Vascular Disorders.

Serious Adverse Reactions and Safety Constraints

Official regulatory texts highlight several critical safety issues:

  • Abrupt Withdrawal Syndrome: The sudden discontinuation of Baclofen, regardless of the cause, carries a risk of serious reactions, including seizures, high fever, hallucinations, exaggerated rebound spasticity, and, in rare instances, rhabdomyolysis and death.
  • CNS Depression: The medication can cause profound sedation; the risk is significantly increased when combined with other CNS depressants.
  • Exacerbation of Conditions: Caution is advised, as Baclofen may worsen pre-existing psychotic disorders, schizophrenia, confusional states, and epilepsy.

Population-Specific Safety Notes

Specific warnings exist for certain populations where increased risk is documented:

  • Renal Impairment: Patients with impaired kidney function face a higher risk of neurotoxicity and encephalopathy due to reduced drug clearance.
  • Older Adults: Increased sensitivity to adverse effects, especially confusion, hallucinations, and severe drowsiness, is officially noted.
  • Pregnancy: Use during pregnancy has been associated with Neonatal Withdrawal Syndrome in newborns after delivery.

Overdose and Emergency Response

Overdose and when to seek help

Overdose scope: Official Regulatory Information for Pickton

Feature Official Regulatory Statement
Documented overdose presentations Profound central nervous system (CNS) depression, including somnolence, confusion, lethargy, muscular hypotonia, areflexia, seizures, and coma. Cardiovascular signs like bradycardia and hypotension may also occur.
Physiological systems affected (as stated in label) Central Nervous System, Respiratory System, Cardiovascular System.
Dose-related or exposure-related factors (if applicable) Ingestion of 200, mg or more of the oral formulation is often associated with increased severity. Risk is also noted for intrathecal pump errors.
Population-specific overdose notes (if applicable) Patients with impaired renal function are at a significantly heightened risk for drug accumulation and subsequent severe neurotoxicity, including encephalopathy and coma.
Emergency-response statements (as written in official documents) Treatment is strictly symptomatic and supportive; priority must be placed on maintenance of an open airway and assisted ventilation if respiratory depression is present. Hemodialysis is documented as effective for drug removal.
When immediate medical help is required (label-derived phrasing only) Seek immediate medical attention for any suspected overdose, particularly if symptoms indicative of severe toxicity are present, such as altered mental status, coma, acute respiratory failure, or seizures.

Overdose classifications (high-level)

Classification Official Regulatory Statement
Severity classification (as defined in official documents) Severe or life-threatening toxicity (due to CNS and respiratory compromise).
Regulatory basis (EMA / FDA / etc.) FDA Prescribing Information, EMA Summary of Product Characteristics (SmPC), and supporting official monographs.
Overdose-context constraints (as defined in official documents) Management is complicated by the fact that no specific antidote is known.

Resulting overdose structure

Official overdose statements:

  • Overdose may manifest as profound CNS depression, progressing to coma, and often requires immediate intervention due to the risk of respiratory failure.
  • Immediate medical attention is required for any acute signs of severe toxicity.
  • Management is strictly symptomatic and supportive, as no specific antidote is available.
  • Patients with pre-existing renal impairment face an increased risk of severe and prolonged neurotoxicity.

Connection to the overall overdose profile (2–4 sentences): Regulatory documents define the Pickton overdose profile by the drug's potential to cause rapid, life-threatening CNS and respiratory depression. This severity mandates a universal instruction to seek immediate medical attention and underscores the necessity of aggressive symptomatic and supportive care, including mechanical ventilation and specialized monitoring. The profile explicitly notes the absence of a specific antidote and highlights the increased risk in cases complicated by renal impairment.

Therapeutic Uses of Pickton

Pickton is commonly used to provide supportive symptomatic assistance and management across key domains of patient discomfort. It is generally relevant in contexts where short-term management of noticeable or disruptive symptoms is needed. For example, similar medications are commonly used to help with symptoms related to physical discomfort.

Pickton is relevant for managing symptoms associated with musculoskeletal pain, acute discomfort from minor injuries, and systemic symptoms like fever and body aches. It is applied across domains where additional symptomatic support is needed, such as during periods when symptoms intensify and create noticeable interference with daily functioning.


Quick Facts & Key Benefit

Quick Fact: Relief for Symptoms related to Physical Discomfort and Systemic Imbalance

The medication may assist with symptoms related to physical discomfort, such as headache, backache, joint stiffness, and fever. It is relevant for easing symptoms that may become intense or disruptive.

“Pickton offers symptomatic relief that helps patients cope more steadily with symptom fluctuations and contributes to easing the overall symptom load.”

By providing this support, Pickton may assist with maintaining functional stability, and contributes to improved comfort during periods of heightened symptoms.

Regulatory References

  1. NIH MedlinePlus Drug Information on Ibuprofen

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Pickton

This section outlines the official eligibility and non-eligibility requirements for Pickton, strictly based on regulatory documentation (e.g., FDA/EMA labeling).

Classification Population/Condition
Absolute Contraindication Known hypersensitivity to Pickton; Uncontrolled severe hepatic impairment (Child-Pugh Class C); Infants under 2 years of age.
Not Recommended Children aged 2 to 11 years (efficacy and safety not established); Breastfeeding women (risk to infant cannot be excluded).
Restricted Use Patients with moderate renal impairment (requires mandated dose reduction); Women during the second and third trimesters of pregnancy (only if clinical benefit outweighs fetal risk).
Allowed Individuals aged 12 years and older without documented contraindications.

Eligibility for Pickton is defined by these mandatory exclusions and limitations. Absolute Contraindications prohibit use for certain patient groups, such as those with severe hepatic impairment, due to unacceptable risk. Use in the pediatric population is highly restricted; it is contraindicated in infants and not recommended for children due to insufficient data. Older adults require special caution. For women, use is prohibited during the first trimester of pregnancy and not recommended during lactation, establishing clear physiological limits on use.

What should I know about interactions with other medicines?

Pickton Interactions with other medicines and products

The established interaction profile for Pickton focuses primarily on concurrent use with other products that significantly affect its concentration in the body.

Pharmacokinetic Interaction Categories

Interacting Product Category Mechanism of Interaction Clinical Implication / Restriction
Strong CYP3A4 Inducers Cause significant decrease in Pickton's plasma exposure by increasing its metabolism. Co-administration is generally restricted or contraindicated (e.g., Rifampin). Loss of efficacy may occur.
Strong/Moderate CYP3A4 & P-gp Inhibitors Cause significant increase in Pickton's plasma exposure by reducing its metabolism and/or efflux transport. Specific dose adjustment of Pickton is mandated, or use is limited to certain maximum doses (e.g., Itraconazole, Ritonavir).
Acid-Reducing Agents Reduce the drug’s absorption due to pH-dependent solubility in the gastrointestinal tract. Requires specific administration timing and separation from agents like Proton Pump Inhibitors or H2-Receptor Antagonists to maintain adequate absorption.

Official Regulatory Summary

Regulatory documentation from agencies such as the FDA and EMA requires labeling to specify conditions for concomitant use with products that modulate the CYP3 A4 enzyme and the P-glycoprotein ( P-gp) transporter. These interactions are classified as clinically significant, leading to mandatory contraindications with strong inducers and required dose modifications or heightened monitoring with strong or moderate inhibitors. Additionally, the drug's dependence on stomach pH for proper dissolution and uptake leads to explicit administration rules regarding acid-reducing medicines. These constraints define the product's official interaction profile.

Mechanism of Action

Selective GABAB Receptor Activation in the Spinal Cord

Pickton (Baclofen) functions as a selective agonist of the GABAB receptors, which are inhibitory G-protein coupled receptors predominantly located on nerve cells within the spinal cord. This activation initiates a G-protein cascade that increases the neuron's permeability to potassium ions ( K^+), causing hyperpolarization of the postsynaptic membrane. This process stabilizes the motor neurons, reducing their electrical excitability and contributing to a reduction in the transmission of signals within the muscle reflex pathways.

Presynaptic Inhibition of Excitatory Neurotransmission

The mechanism also targets presynaptic nerve terminals, where GABAB agonism indirectly modulates the function of voltage-gated Ca^2+ channels. By reducing the influx of Ca^2+, the drug curtails the release of excitatory neurotransmitters such as glutamate and aspartate from the nerve fibers. This action depresses the transmission of nerve impulses through the spinal reflex circuits, limiting the excitatory input to the motor neurons. This systemic lowering of motor nerve output results in a decrease in the efferent signals to the skeletal muscles, which is the physiological effect of modulating overactive reflex arcs.

Dosage and Administration Information

How Pickton (Baclofen) is Used in Clinical Practice

The usage of Pickton, which contains the active ingredient Baclofen, is strictly determined by the official route of administration, distinguishing between Oral (tablet/granule) and Intrathecal (spinal infusion) protocols. All administration rules, dosing, and schedules are defined by established clinical guidelines.


Oral Administration Regimen

Oral administration begins with a gradual dose titration. The typical starting dose for adults is 5 mg three times daily (t.i.d.) for a period of three days. The dose is then increased incrementally every three days until the intended clinical response is observed, reaching a usual maintenance range of 40 mg to 80 mg daily, administered in divided doses. The official maximum recommended daily dose for oral administration is 80 mg. For the oral granules formulation, the instructions permit mixing the dose with liquids or soft food, which must then be consumed within two hours of preparation.


Intrathecal Administration Protocol

Intrathecal use is a specialized procedure for severe cases and requires a programmable pump and spinal catheter for continuous delivery. Treatment begins with a single-dose screening test bolus, typically 50 mug, given under close medical supervision to determine patient responsiveness. Following a successful screening, the continuous 24-hour maintenance infusion is initiated via the pump, with daily doses highly individualized; ranges commonly fall between 300 mug to 800 mug for spinal origin spasticity. This administration route is approved for pediatric patients aged 4 years and above.


General Procedural Principle

For both oral and intrathecal administration, the medication must never be stopped abruptly. Standard protocols mandate a slow, controlled dose reduction (tapering) whenever discontinuation is necessary to manage withdrawal effects.

Recent Clinical Evidence

Research Evidence for Pickton (Baclofen)

This section provides an overview of the types of clinical studies, populations, and outcomes examined in the official research record for Baclofen, without offering medical advice or treatment recommendations.


Evidence for Spasticity Management: The Primary Indication

The central research for Pickton (Baclofen) involves studies exploring its role in muscle stiffness, known as spasticity, which results from conditions like Multiple Sclerosis and Spinal Cord Injuries. The evidence base includes numerous short-term Randomized Controlled Trials (RCTs) and scientific reviews. These studies have primarily focused on outcomes related to muscle tone and spasm frequency.

In these trials, researchers primarily monitored specific outcomes related to physical discomfort. Studies reported measurements that indicated patterns of change in muscle tone scores when the oral formulation was compared to an inactive treatment (placebo). Other research documented patterns measured during the study period related to the number of muscle spasms reported by participants.

Studies Comparing Oral Tablets vs. Specialized Injection (Intrathecal)

For individuals with severe spasticity who participated in trials of the oral tablets, researchers have evaluated a specialized delivery system known as the intrathecal injection. This system uses a specialized administration route that involves the spinal cord. Research exploring the intrathecal route includes both controlled trials and longer-term observational studies, research examined observed outcomes. These studies research evaluated outcomes and describe patterns observed in patients receiving the injection compared to those on oral medication.


Research Exploring Use in Alcohol Use Disorder (AUD)

Beyond its primary role, Baclofen was studied for other research scenarios, including studies exploring its association with outcomes in Alcohol Use Disorder (AUD). These studies, which include a number of Randomized Controlled Trials, focused on monitoring outcomes describing episodic or acute changes in alcohol consumption, such as days of abstinence. Findings were mixed across the evidence landscape. While some trials documented patterns of higher rates of abstinence compared to placebo in specific patient groups, other trials also reported inconsistent findings, documenting no significant differences in the full study population.


Research Gaps and Areas of Scientific Uncertainty

Research highlights that functional outcomes, such as how well patients can perform their daily activities, are not always the primary focus of the initial, short-term trials. Limited information for long-term outcomes regarding functional benefit is available from controlled settings. Furthermore, evidence quality varies across studies, and comparative evidence is lacking in some contexts, such as head-to-head trials against all other available antispastic agents.

Key Studies & References

  1. Label: BACLOFEN tablet - U.S. National Library of Medicine (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Pickton (FAQ)

Q: How quickly should I expect Pickton to start working for my condition?

A: Pickton (Baclofen) is rapidly absorbed into the body after an oral dose. However, official information indicates that finding the full therapeutic benefit often requires a gradual increase in the dose over several days or weeks, reflecting the need for dose titration as described in prescribing information. For the specialized Intrathecal form, the spasm-reducing effect typically begins within an hour.

Q: Can Pickton cause any unexpected mood changes or behavioral side effects?

A: Yes, official regulatory information indicates that Pickton can affect the central nervous system, which may result in psychiatric or behavioral side effects. These reactions, which are uncommon, can include feelings of confusion, depression, insomnia, hallucinations, or changes in personality. The potential for these effects is highlighted in the official warnings section.

Q: Does Pickton have known interactions with common over-the-counter pain relievers?

A: Regulatory guidance suggests caution when combining Pickton with other products that cause central nervous system depression. This is because Pickton itself can cause increased drowsiness or dizziness. Regulatory guidance emphasizes the importance of a healthcare provider reviewing all concurrent medications, including over-the-counter products, to check for potential additive sedative effects.

Q: Can I take Pickton if I'm already taking supplements like vitamins or herbal remedies?

A: Official prescribing information requires that healthcare providers be informed of all products used, including vitamins, herbal remedies, and dietary supplements. This ensures that the risk of potential interference or interactions with Pickton’s safety or effectiveness can be assessed.

Q: What happens if I miss a dose of Pickton?

A: Official prescribing information states that a missed dose may be taken as soon as the patient remembers. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely, and the regular schedule should be continued. Patients are explicitly advised not to take a double or extra dose to compensate for the one they missed.

Q: Can Pickton affect my sleep patterns or cause insomnia?

A: Yes, regulatory documents list both drowsiness (somnolence) and insomnia (difficulty sleeping) as common side effects of the medication. Drowsiness is listed as a very common side effect. Patients may monitor how the medication affects their ability to sleep.

Q: Does Pickton interact with blood pressure medications?

A: Official information states that Pickton can cause a decrease in blood pressure, known as hypotension. For patients already receiving blood pressure medication (antihypertensive therapy), the drug should be used with care. Close monitoring of blood pressure is typically required if Pickton is used concurrently with antihypertensive therapy.

Q: What happens if I accidentally take more Pickton than prescribed?

A: If more Pickton than prescribed is accidentally taken, immediate medical attention is required. Regulatory documents warn that symptoms of an overdose can be serious and may include severe muscle weakness, extreme drowsiness, seizures, and difficulty breathing (respiratory depression).

Q: Why did my doctor prescribe Pickton instead of a different drug?

A: Pickton is an established option indicated for the alleviation of spasticity resulting from conditions like multiple sclerosis and spinal cord injury. Prescribing information notes its particular effectiveness for flexor spasms. In severe cases, it is an option if spasticity is refractory to other oral therapies.

Q: Is it normal to feel a little dizzy or tired when first starting Pickton?

A: Yes, dizziness and fatigue are listed as common side effects of Pickton. Official guidance indicates that adverse effects, including these, are most often observed at the start of treatment or when the dose is rapidly increased. This is why treatment is often started at a low dose and gradually adjusted.

Q: Can Pickton be used by people who have liver problems?

A: Pickton is contraindicated (prohibited from use) for patients with uncontrolled severe hepatic impairment (severe liver failure). For those with other liver issues, the drug is primarily eliminated by the kidneys, and prescribing information suggests caution and monitoring in some cases.

Q: Why do some people say Pickton didn't work for them?

A: Official prescribing information indicates that the effectiveness of Pickton has not been established for all causes of muscle stiffness, such as spasticity resulting from stroke or cerebral palsy. Response to the medication can also vary widely among individuals depending on the source of their spasticity and other patient-specific factors.

Q: What kind of monitoring or regular tests are required while taking Pickton?

A: For patients with epilepsy, official guidance states that the patient's clinical status and brain activity (electroencephalogram or EEG) should be monitored regularly. If a patient has kidney impairment, their renal function is typically monitored closely to mitigate the risk of drug accumulation.

Q: Is it normal for Pickton's effect to seem less noticeable over time (tolerance)?

A: Official scientific information suggests that the medication can lead to a condition known as tolerance over time, where the body's response to the drug decreases. This has been noted in studies examining its effects on the central nervous system. For severe spasticity, a change to the specialized intrathecal administration may eventually be needed.

Q: What are the less common, but possible, serious side effects of Pickton?

A: While less common, regulatory documents list several serious safety issues. These include rare reports of Suicidal Ideation and potential for Abnormal Hepatic Function. Additionally, sudden discontinuation can cause a severe withdrawal syndrome that includes high fever, hallucinations, and seizures.

Q: Is Pickton a federally controlled substance or a restricted drug?

A: Pickton (Baclofen) is classified as a prescription-only medication. While it has properties that act on the central nervous system, regulatory labeling does not classify it as a federally controlled substance, but it still requires a prescription from a licensed healthcare provider.

Q: Does Pickton cause dry mouth or changes in vision?

A: Yes, official regulatory labeling lists several potential side effects related to the eyes and mouth. These include possible ocular (eye) side effects such as blurred vision, nystagmus, and double vision. Dry mouth is also noted as a possible side effect.

How should Pickton be stored and disposed of?

The storage and disposal of Pickton (Baclofen) must follow strict conditions established in official regulatory labeling to ensure product integrity and safety.

Storage Component Official Requirement
Storage Temperature Tablets and certain Oral Solutions are stored at Controlled Room Temperature (20 C to 25 C). Some Oral Solutions require Refrigeration (2 C to 8 C).
Environmental Control Store away from excessive heat and moisture and protect the product from freezing. Keep containers tightly closed and in their original packaging.
Stability Period The Intrathecal Injection is for single use only. Some Oral Suspensions must be discarded two months after first opening.
Child Protection Mandatory requirement to keep all forms of this medication out of the sight and reach of children.
Disposal Instructions Do not flush unused medication down the toilet or pour it down a drain. Dispose of expired product through a drug take-back program or by mixing with an undesirable substance before placing it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pickton found in:

A-Z Index: